Immune Checkpoint Inhibitors for the Treatment of Bladder Cancer

SIMPLE SUMMARY: In this review, we examined relevant clinical trial results with immune checkpoint inhibitors in patients with metastatic urothelial cancer. We also focused on the potential of immunotherapy in the adjuvant and neoadjuvant setting or as part of drug combinations. Finally, we briefly...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Cancers (Basel)
Hlavní autoři: Lopez-Beltran, Antonio, Cimadamore, Alessia, Blanca, Ana, Massari, Francesco, Vau, Nuno, Scarpelli, Marina, Cheng, Liang, Montironi, Rodolfo
Médium: Artigo
Jazyk:Inglês
Vydáno: MDPI 2021
Témata:
Review
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7795541/
https://ncbi.nlm.nih.gov/pubmed/33401585
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/cancers13010131
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky